| Sector |
Agriculture
|
Compare with Sector peers |
| Industry |
Floriculture
|
Compare with Industry peers |
| Website | http://www.indrayani.com | |
| Market Cap | 258.42 Cr. | |
| Enterprise Value(EV) | 305.51 Cr. | 2022-09 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | 1.33 | Trailing Twelve Months Ending 2022-09 |
| Price-Earning Ratio (PE) | 56.94 | Trailing Twelve Months Ending 2022-09 |
| Industry PE | 70.75 | Trailing Twelve Months Ending 2022-09 |
| Book Value / Share | 13.04 | Trailing Twelve Months Ending 2022-09 |
| Price to Book Value | 5.79 | Calculated using Price: 75.50 |
| Dividend Yield | 0.00 | Period Ending 2022-03 |
| No. of Shares Subscribed | 3.42 Cr. | 34,227,192 Shares |
| FaceValue | 10 | |
| Company Profile | ||
| The company was incorporated on March 9, 1992 and it was converted into a public limited company on March 13, 1992. It is into floriculture and is engaged in the cultivation of cut flowers, plantlets and seeds. | ||
| 1 Day |
|
+7.88% |
| 1 Week |
|
+12.58% |
| 1 Month |
|
+5.71% |
| 3 Month |
|
-10.54% |
| 6 Month |
|
+39.23% |
| 1 Year |
|
+190.37% |
| 2 Year |
|
+832.99% |
| 5 Year |
|
+1451.43% |
| 10 Year |
|
| 5 years | 2011-03 | 2012-03 | 2020-03 | 2021-03 | 2022-03 | |
| Return on Equity (%) | -2.84 | -1.85 | 43.42 | -112.29 | 20.23 | |
| Return on Capital Employed (%) | 16.17 | 7.69 | 7.85 | -23.16 | 16.38 | |
| Return on Assets (%) | -0.87 | -0.59 | 2.53 | -24.50 | 9.71 |
| Particulars | 6 years | 2011-03 Rs. Cr. | 2012-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
| Shh. Funds | 4 | 3 | 31 | 20 | 24 | 54 | |
| Non Curr. Liab. | 2 | 0 | 7 | 8 | 7 | 27 | |
| Curr. Liab. | 4 | 9 | 14 | 12 | 19 | 50 | |
| Minority Int. | 0 | 0 | -10 | ||||
| Equity & Liab. | 10 | 12 | 51 | 40 | 51 | 121 | |
| Non Curr. Assets | 6 | 6 | 32 | 31 | 32 | 67 | |
| Curr. Assets | 4 | 7 | 19 | 9 | 19 | 54 | |
| Misc. Exp. not W/O | 0 | ||||||
| Total Assets | 10 | 12 | 51 | 40 | 51 | 121 |
| Particulars | 6 years | 2011-03 Rs. Cr. | 2012-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09 Rs. Cr. TTM |
| Net Sales | 39 | 58 | 50 | 21 | 62 | 100 | |
| Other Income | 0 | 0 | 0 | 0 | 3 | ||
| Total Income | 39 | 58 | 50 | 21 | 62 | 103 | |
| Total Expenditure | -39 | -57 | -47 | -26 | -55 | -88 | |
| PBIDT | 1 | 1 | 3 | -5 | 7 | 15 | |
| Interest | 0 | 0 | -1 | -2 | -2 | -3 | |
| Depreciation | 0 | 0 | -1 | 0 | -1 | -2 | |
| Taxation | 0 | 0 | 0 | ||||
| Exceptional Items | -4 | ||||||
| PAT | 0 | 0 | 1 | -11 | 4 | 10 | |
| Minority Interest | 0 | -5 | |||||
| Share Associate | 0 | ||||||
| Other Related Items | |||||||
| Consolidated Net Profit | 0 | 0 | 1 | -11 | 4 | 5 | |
| Adjusted EPS | 0 | 0 | 2 | -3 | 1 | 1 |
| Particulars | 5 years | 2011-03 Rs. Cr. | 2012-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Cash Fr. Operatn. | 1 | 2 | 6 | 0 | 4 | |
| Cash Fr. Inv. | -3 | 0 | -4 | -1 | -1 | |
| Cash Fr. Finan. | 2 | -1 | -1 | 0 | -3 | |
| Net Change | 0 | 1 | 1 | -1 | 1 | |
| Cash & Cash Eqvt | 0 | 1 | 1 | 1 | 2 |
|
Mon, 06 Feb 2023
Board Meeting Intimation for Considering Unaudited Financial Results Pursuant To Regulation 29 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 Scheduled To Be Held On Tuesday February 14 2023. INDRAYANI BIOTECH LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2023 inter alia to consider and approve 1. The Unaudited Financial Results (standalone and consolidated) of the Company for the quarter ended December 31 2022. 2. Any other business with the permission of the Chair. |
|
Fri, 13 Jan 2023
Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Operation Management Of Vaasan Medical Center (India) Private Limited. We wish to inform that the Operation Management of Vaasan Medical Center India Private Limited is being taken over by IBL Healthcare Limited a wholly-owned subsidiary of Indrayani Biotech Limited. |
|
Sat, 07 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 In compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 we are enclosing herewith the copy of Certificate received from M/s. Link Intime India Private Limited the Registrar and Transfer Agent (RTA) of the Company for the Quarter ended December 31 2022. |
| Tue, 07 Feb 2023 |
High Delivery Percentage
|
Higher Delivery Quantity
|
Higher Delivery Quantity and Percentage
|
Higher Trade Quantity
|
Higher Trade and Delivery Quantity
|
Equities
M.F.
Sectors